Judge Dismisses Mylan’s Antitrust Claims Against Teva Over Copaxone in Legal Setback

A federal judge in New Jersey has rejected efforts by Mylan to revive antitrust claims against Teva Pharmaceuticals regarding its multiple sclerosis drug, Copaxone. This decision came after endorsing a special master’s recommendations to dismiss certain claims from Mylan and other entities like Walgreens. The allegations involved accusations that Teva engaged in regulatory deception and…

Read More

Hikma Pharmaceuticals Seeks Supreme Court Intervention in Landmark Patent Case Over “Skinny Label” Strategy

In a significant legal maneuver, Hikma Pharmaceuticals USA Inc. has appealed to the U.S. Supreme Court, asserting that the Court’s recent decision in a copyright case involving an internet company supports its position in an ongoing patent dispute. The case at hand involves Hikma’s generic version of a heart medication originally developed by Amarin Pharma…

Read More

Genius Sports Seeks Court Order for Panda Interactive’s Settlement Reveal in Patent Litigation Battle

In a legal maneuver illustrating the competitive dynamics of the sports technology industry, Genius Sports Ltd. has requested that a Texas federal court compel Panda Interactive to disclose a settlement agreement reached in a previous patent lawsuit. This request is rooted in Genius Sports’ ongoing effort to obtain discovery materials that may be crucial in…

Read More

FN Herstal Sues Glock in Key Patent Battle Over Pistol Design Features

In a recent development in the firearms industry, FN Herstal, a prominent Belgian gun manufacturer, has initiated legal proceedings against Glock Inc., asserting that the Austrian company’s latest offering, the Glock Gen6 pistols, infringes on their patent. The lawsuit, filed in Georgia federal court, specifically targets Glock’s design feature that allows users to attach optic…

Read More

Heartflow Inc. Sues Ex-Consultant for Alleged Patent Infringement in AI Cardiac Imaging

AI-powered cardiac imaging company Heartflow Inc. has filed a legal complaint against a former consultant, alleging patent infringement and misappropriation of trade secrets. The lawsuit targets a competitor founded by the ex-consultant, who Heartflow claims improperly accessed and used proprietary technology during his tenure with the company. According to a report by Law360, this action…

Read More

GAO Calls for Reform of Bayh-Dole Act Reporting to Enhance Innovation Compliance

In recent developments, the U.S. Government Accountability Office (GAO) has highlighted issues with the Bayh-Dole Act reporting requirements, which are pivotal for universities and businesses holding patent rights on inventions developed with federal funding. The reporting complexities are becoming a bottleneck for compliance, leading to potential inefficiencies in the patent process (Law360). Under the provisions…

Read More

Federal Circuit Upholds Patent Board Ruling Against AlmondNet, Affirming Meta’s Legal Win in Ad Tech Dispute

In a recent legal development, the Federal Circuit has upheld the Patent Trial and Appeal Board’s decision involving Meta Platforms Inc. The ruling confirmed the invalidation of all claims challenged by Meta against a patent held by AlmondNet Inc., a company specializing in advertising technology. The court’s decision, delivered on Monday, signals a continued trend…

Read More

Federal Circuit Upholds Patent Validity in Cisco-Ramot Case, Reinforcing University Innovation Rights

The U.S. Court of Appeals for the Federal Circuit recently held firm in its decision to reject Cisco Systems Inc.’s effort to reinstate challenges to two patents held by Ramot at Tel Aviv University. These patents, which concern data conversion technology, were under scrutiny as Cisco questioned their validity. However, the Federal Circuit supported the…

Read More

U.S. ITC to Investigate Potential Patent Infringement in Lidocaine Patch Imports

On Monday, the U.S. International Trade Commission (ITC) announced that it will investigate whether imported over-the-counter lidocaine patches sold by five companies infringe upon a U.S. patent. This investigation could potentially lead to exclusion orders preventing these products from entering the U.S. market, a significant move within the realm of international trade and patent law….

Read More

Federal Circuit Affirms PTAB Ruling, Reinvigorating Patent Claim Standards in Tech Sector

The Federal Circuit recently upheld a ruling by the Patent Trial and Appeal Board (PTAB), affirming the invalidity of claims within a contested video-decoding patent. This decision came after the patent holder argued against the restrictions on presenting written description support during the proceedings. This verdict impacts the domain of intellectual property, reinforcing the standards…

Read More

USPTO Launches Pilot Program to Streamline Patent Examination Amid Backlog Concerns

The U.S. Patent and Trademark Office (USPTO) has announced a pilot program that hopes to streamline the patent examination process, addressing long-standing concerns over examination backlogs. The program, revealed on April 10, 2026, introduces a new requirement for certain applicants in the national stage to actively request the examination of their patent applications, a move…

Read More

U.S. Federal Circuit Upholds Microsoft’s Victory in Mobile Architecture Patent Case

In a significant decision for intellectual property and technology law, the U.S. Court of Appeals for the Federal Circuit upheld the Patent Trial and Appeal Board’s (PTAB) ruling, affirming that Microsoft Corporation successfully demonstrated the invalidity of claims from Lemko Corp.’s distributed mobile architecture patent. This comes as an important development in the ongoing interplay…

Read More

Federal Circuit’s Approach to Trade Secret Law Signals Significant Shift in Intellectual Property Strategy

The Federal Circuit’s evolving view of trade secrets represents a significant shift in the landscape of intellectual property law. Traditionally governed by common law and the Uniform Trade Secrets Act (UTSA), as adopted by individual states, trade secret law saw a change with the introduction of the federal Defend Trade Secrets Act (DTSA) in 2016….

Read More

Federal Circuit Affirms PTAB’s Rejection of Sentient Sensors Patent Claims, Emphasizes Stringent Innovation Standards

The United States Court of Appeals for the Federal Circuit recently decided to uphold the Patent Trial and Appeal Board’s (PTAB) conclusion that claims associated with a Sentient Sensors monitoring patent lacked innovation and were therefore deemed obvious. The case revolved around patent claims concerning technology employed in military instrument monitoring systems. The Federal Circuit’s…

Read More

Federal Circuit Upholds PTAB Ruling Against Remote-Control Patents, Favoring Roku in Streaming Tech Dispute

The U.S. Court of Appeals for the Federal Circuit recently upheld a decision by the Patent Trial and Appeal Board (PTAB), which invalidated certain patent claims related to remote-control technology asserted against Roku Inc. The affirmation on Friday further cements Roku’s legal standing in a protracted battle over the intellectual property rights associated with its…

Read More

Blank Rome Strengthens Intellectual Property Practice with Key Patent Lawyer Hires in Chicago and Dallas

Blank Rome LLP, a prominent law firm known for its comprehensive legal services, has strategically expanded its patent practice by hiring two seasoned patent lawyers in Chicago and Dallas. This move signals the firm’s focus on enhancing its intellectual property capabilities across different regions. In Chicago, Blank Rome has welcomed Edward Chadwick, formerly of Troutman…

Read More

Federal Circuit’s Deliberation on Patent Marking Could Reshape Intellectual Property Law

In a recent development that could pave the way for legal clarity, the Federal Circuit’s Chief Judge indicated the potential for establishing a clear precedent concerning the role of patent marking in admissionless settlements. This statement emerged during a hearing where attorney William Ramey faced criticism from a Federal Circuit panel over his conduct in…

Read More

Federal Circuit Chief Judge Advocates for Clearer IP Marking Standards Amid Patent Litigation Criticisms

Amidst recent legal proceedings involving patent litigation, the Chief Judge of the Federal Circuit has articulated the potential necessity for a clear standard concerning the marking of intellectual property rights. The remarks were made during a session where the panel criticized attorney William Ramey for his conduct in a failed 3D glasses patent case against…

Read More

Patco Brands Challenges BuzzBallz in Federal Court Over Domain Dispute, Alleging Anticompetitive Cybersquatting

In a recent legal development, Patco Brands has contested BuzzBallz’s acquisition of web domains associated with Patco’s forthcoming products, labeling the move as both unfunny and unlawful. BuzzBallz, a producer of ready-to-drink cocktails, had previously claimed that the purchase was intended as a joke. Patco Brands, however, argues that this action constitutes anticompetitive cybersquatting and…

Read More

“U.S. Patent Review Reforms Ignite Debate Over Efficiency and Stability in Intellectual Property Law”

The U.S. Patent and Trademark Office’s recent overhaul of patent review practices has caused a stir among legal professionals and industry experts, with substantial debate evident at a recent conference. Many attorneys have voiced apprehensions about increased uncertainty, while the potential for policy shifts between administrations was noted by a former agency director. These concerns…

Read More

Welch’s Fruit Snacks Launches ITC Action Against Cibo Vita Over Patent Dispute in Yogurt Snack Market

In a recent development, the manufacturer behind Welch’s Fruit Snacks has initiated proceedings at the U.S. International Trade Commission (ITC) against Cibo Vita, accusing the firm of patent infringement concerning its yogurt-covered snacks. The case highlights ongoing tensions in the competitive fruit snack market, as companies strive to protect their innovations in packaging and product…

Read More

EmblemHealth Challenges Alexion’s Soliris Patent Practices in Federal Court Appeal

EmblemHealth is making a significant legal move in its ongoing dispute with AstraZeneca’s unit Alexion Pharmaceuticals. The nonprofit insurer has petitioned a federal judge in Massachusetts to allow an appeal to the First Circuit. This appeal challenges a decision that significantly reduced the scope of its class action suit, alleging that Alexion utilized questionable patent…

Read More